Not applicableUnknownNCT00449319What this trial is testingAML Treatment in Untreated Adult PatientsWho this might be right forLeukemia, Myelocytic, Acute Gruppo Italiano Malattie EMatologiche dell'Adulto
Not applicableUnknownNCT03062436What this trial is testingTo Study the Impact of Stopping Therapy in Patients of CML With Molecular RemissionWho this might be right forChronic Myeloid LeukemiaTreatment Free Remission Command Hospital, India 27
Not applicableUnknownNCT04422171What this trial is testingA 12-month Real Life Study of IBD Patients Switched From Adalimumab Originator Humira® to One of Its BiosimilarWho this might be right forIBD Patients, Originator Treatment, Biosimilar, Switch Back University Hospital, Grenoble 400
Not applicableUnknownNCT05926128What this trial is testingStudy of Treatment Free Remission in Patients With Chronic Myeloid Leukemia in Chronic PhaseWho this might be right forCML Fundaleu 75
Testing effectiveness (Phase 2)Active Not RecruitingNCT03610971What this trial is testingTreatment Free Remission After Combination Therapy With Ruxolitinib Plus Tyrosine Kinase InhibitorsWho this might be right forChronic Phase Chronic Myeloid LeukemiaChronic Myeloid Leukemia, Chronic Phase H. Lee Moffitt Cancer Center and Research Institute 24
Large-scale testing (Phase 3)Active Not RecruitingNCT04971226What this trial is testingOral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CPWho this might be right forChronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive Novartis Pharmaceuticals 405
Testing effectiveness (Phase 2)Looking for participantsNCT04838041What this trial is testingProtocol Number: HJKC3-0003. Treatment Free Remission After Asciminib Based Therapy in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI DiscontinuationWho this might be right forChronic Phase Chronic Myelogenous Leukemia Medical College of Wisconsin 51
Testing effectiveness (Phase 2)Study completedNCT01301820What this trial is testingElderly Patients With Acute Myeloid Leukemia (AML), Maintenance Phase After Complete Remission (CR)Who this might be right forAcute Myeloid Leukemia French Innovative Leukemia Organisation 120
Post-approval studies (Phase 4)Study completedNCT02177071What this trial is testingA proSpective Randomized Controlled Trial comParing infliximAb-antimetabolites Combination Therapy to Anti-metabolites monotheRapy and Infliximab monothErapy in Crohn's Disease Patients in Sustained Steroid-free Remission on Combination TherapyWho this might be right forCrohn's Disease Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives 211
Post-approval studies (Phase 4)UnknownNCT02602314What this trial is testingSustained Treatment-free Remission in BCR-ABL+ Chronic Myeloid LeukemiaWho this might be right forChronyc Myeloid Leukemia Gruppo Italiano Malattie EMatologiche dell'Adulto 450
Testing effectiveness (Phase 2)Study completedNCT02852486What this trial is testingStudy of Imatinib Discontinuation in Chronic Myeloid Leukemia With Deep Molecular ResponseWho this might be right forLeukemia, Chronic Myeloid University of Campinas, Brazil 31
Large-scale testing (Phase 3)Active Not RecruitingNCT05456191What this trial is testingInvestigate Tolerability and Efficacy of Asciminib (Oral) Versus Nilotinib (Oral) in Adult Participants (≥18 Years of Age) With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia in Chronic Phase (Ph+ CML-CP)Who this might be right forPhiladelphia Chromosome-Positive Chronic Myeloid Leukemia Novartis Pharmaceuticals 568
Not applicableStudy completedNCT04546243What this trial is testingOsteosarcoma With Resectable Pulmonary Metastasis: A Retrospective StudyWho this might be right forOsteosarcoma MetastaticPulmonary DiseaseResectable Sarcoma+1 more Peking University People's Hospital 127
Not applicableLooking for participantsNCT05439889What this trial is testingFollow-up Study on Chronic Myeloid Leukemia Patients Achieving Treatment-free RemissionWho this might be right forChronic Myeloid Leukemia, BCR/ABL-Positive National Taiwan University Hospital 100
Large-scale testing (Phase 3)Active Not RecruitingNCT05413915What this trial is testingAsciminib Used in Consolidation With Imatinib vs. Imatinib to Achieve TFR in CP-CMLWho this might be right forChronic Myeloid LeukemiaChronic Myeloid Leukemia, BCR/ABL-PositiveChronic Myeloid Leukemia in Remission Sarit Assouline 164
Large-scale testing (Phase 3)Study completedNCT02980731What this trial is testingA Study Evaluating the Impact of Venetoclax on the Quality of Life for Subjects With Relapsed (Your Cancer Has Come Back) or Refractory (no Response to Previous Cancer Treatments) Chronic Lymphocytic Leukemia (CLL) While Receiving Venetoclax Monotherapy (a Single Agent).Who this might be right forChronic Lymphocytic Leukemia (CLL) AbbVie 210
Testing effectiveness (Phase 2)Study completedNCT01744665What this trial is testingA Study That Switched Patients From Imatinib to Nilotinib and Then Was Followed by Treatment CessationWho this might be right forCML Novartis Pharmaceuticals 59
Testing effectiveness (Phase 2)Looking for participantsNCT04698785What this trial is testingEfficacy of Regorafenib Combined With Best Supportive Care as Maintenance Treatment in High Grade Bone Sarcomas PatientsWho this might be right forBone SarcomaOsteosarcoma Centre Leon Berard 36
Testing effectiveness (Phase 2)UnknownNCT02268370What this trial is testingTreatment-free Remission Accomplished With Dasatinib in Patients With CMLWho this might be right forChronic Myeloid Leukemia University Health Network, Toronto 131
Testing effectiveness (Phase 2)Study completedNCT01698905What this trial is testingTreatment-free Remission After Achieving Sustained MR4.5 on Nilotinib (ENESTop)Who this might be right forChronic Myeloid Leukemia Novartis Pharmaceuticals 163